| Literature DB >> 20140911 |
Jessica N Landis1, Coleen T Murphy.
Abstract
In a remarkably conserved insulin signaling pathway that is well-known for its regulation of longevity in worms, flies, and mammals, the major C. elegans effector of this pathway, DAF-16/FOXO, also modulates many other physiological processes. This raises the question of how DAF-16/FOXO chooses the correct targets to achieve the appropriate response in a particular context. Here, we review current knowledge of tissue-specificity and interacting partners that modulate DAF-16/FOXO functional output. Copyright (c) 2010 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20140911 PMCID: PMC3811053 DOI: 10.1002/dvdy.22244
Source DB: PubMed Journal: Dev Dyn ISSN: 1058-8388 Impact factor: 3.780